Concourse Financial Group Securities’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
371
2024
Q4
Hold
0
2505
2024
Q3
Hold
0
2494
2024
Q2
Hold
0
2548
2024
Q1
Hold
0
2559
2023
Q4
Hold
0
2520
2023
Q3
Hold
0
2547
2023
Q2
Hold
0
2561
2023
Q1
Hold
0
2586
2022
Q4
Hold
0
2526
2022
Q3
Hold
0
2277
2022
Q2
Hold
0
2400
2022
Q1
Hold
0
2367